Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-inflammatory effects of tiotropium in patients with stable COPD
2018-002173-22Phase 4Active
- Sponsor
- University Medical Center Groningen
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of tiotropium in chronic obstructive pulmonary disease (COPD), sponsored by University Medical Center Groningen. Primary endpoint: Leukotriene B4 in induced sputum. Started Nov 2018; status: active.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2018-002173-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002173-22.